| Application no. and date | 94202304.5 (espacenet) (Federated) (European Patent Register), 19940811 | | Patent/reg. no. and date | DK/EP 0638554, 19971022 | | Publication date | 19950215 | | Priority no. and date | GB 9316863, 19930813 | | EP pub. no. and date |
EP 0638554 19950215 | | Effective date | | | Applicant/owner | GLAXO GROUP LIMITED, Glaxo Wellcome House
Berkeley Avenue
Greenford, Middlesex UB6 0NN, GB | | Applicant ref. no. | 3802 | | Inventor | Latham, William David Stuart, Glaxo Research and Dev. Limited, Park Road, Ware, Herts. SG12 0DP , GB,
Goodyear,Michael David, Glaxo Research and Dev. Limited, Park Road, Ware, Herts. SG12 0DP , GB,
Whitehead, Andrew Jonathan, Glaxo Res. and Devel. Limited, Park Road, Ware, Herts. SG12 0DP , GB | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | C07D 211/58 | | Title | Fremgangsmåde til fremstilling af et N-phenyl-N-(4-piperidinyl)amidderivat | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
